Literature DB >> 15844290

The cost-effectiveness of the English smoking treatment services: evidence from practice.

Christine Godfrey1, Steve Parrott, Tim Coleman, Elspeth Pound.   

Abstract

AIMS: To investigate the cost-effectiveness of English specialist smoking cessation services.
DESIGN: Combination of observational cost and outcome data from English smoking cessation services to calculate cost-effectiveness ratios. Multivariate analysis of factors influencing variation in services' cost-effectiveness.
SETTING: Fifty-eight of the 92 specialist smoking cessation services in England in 2000/01.
METHODS: Services' costs were estimated using survey data which described services' configurations, staffing, interventions delivered and development. Information on services' throughput and outcomes (as biochemically validated 4-week smoking cessation rates) were obtained from routine sources. With reference to relevant literature and assumptions about relapse and background cessation rates, 4-week cessation rates were converted first to 1-year rates. One-year cessation rates were adjusted to reflect the likely permanent smoking cessation rate attributable to service intervention and finally attributable life-years gained were calculated. A wide variety of sensitivity analyses was performed to test the robustness of the average cost-effectiveness ratio, calculated by combining the cost and life-year gained estimates, for all services. With additional data on deprivation levels in services' areas, ordinary least-squares regression techniques were used to investigate variations in individual services' costs per client and cost-effectiveness ratios.
FINDINGS: Using an up-to-date estimate for health gain accrued by stopping smoking, the average cost per life gained was pound 684 (95% CI 557811), falling to pound 438 when savings in future health-care costs were counted. With the worst case assumptions, the estimate of cost-effectiveness rose to pound 2693 per life-year saved (pound 2293 including future health-care costs) and fell to pound 227 (pound 102) under the most favourable assumptions. Findings are comparable to previous published studies. The regression results suggest that different factors influence cost per client and the net cost per life-year saved, indicating that decision makers should be careful in setting performance targets for these services.
CONCLUSIONS: In 2000/01, English smoking cessation services provided cost-effective services operating well below the benchmark of pound 20,000 per quality-adjusted life-year saved (QALY) that is used by the National Institute for Clinical Excellence in the United Kingdom.

Mesh:

Year:  2005        PMID: 15844290     DOI: 10.1111/j.1360-0443.2005.01071.x

Source DB:  PubMed          Journal:  Addiction        ISSN: 0965-2140            Impact factor:   6.526


  23 in total

Review 1.  Unrelated medical costs in life-years gained: should they be included in economic evaluations of healthcare interventions?

Authors:  David R Rappange; Pieter H M van Baal; N Job A van Exel; Talitha L Feenstra; Frans F H Rutten; Werner B F Brouwer
Journal:  Pharmacoeconomics       Date:  2008       Impact factor: 4.981

2.  Cost-Effectiveness of Integrating Tobacco Cessation Into Post-Traumatic Stress Disorder Treatment.

Authors:  Paul G Barnett; Abra Jeffers; Mark W Smith; Bruce K Chow; Miles McFall; Andrew J Saxon
Journal:  Nicotine Tob Res       Date:  2015-05-04       Impact factor: 4.244

3.  Self-help materials for the prevention of smoking relapse: study protocol for a randomized controlled trial.

Authors:  Fujian Song; Richard Holland; Garry R Barton; Max Bachmann; Annie Blyth; Viv Maskrey; Paul Aveyard; Stephen Sutton; Jo Leonardi-Bee; Thomas H Brandon
Journal:  Trials       Date:  2012-05-30       Impact factor: 2.279

4.  Cost-effectiveness of extended cessation treatment for older smokers.

Authors:  Paul G Barnett; Wynnie Wong; Abra Jeffers; Ricardo Munoz; Gary Humfleet; Sharon Hall
Journal:  Addiction       Date:  2013-12-13       Impact factor: 6.526

5.  Provision of relapse prevention interventions in UK NHS Stop Smoking Services: a survey.

Authors:  Shade A Agboola; Tim J Coleman; Jo A Leonardi-Bee; Andy McEwen; Ann D McNeill
Journal:  BMC Health Serv Res       Date:  2010-07-20       Impact factor: 2.655

6.  Cost-utility analysis of varenicline, an oral smoking-cessation drug, in Japan.

Authors:  Ataru Igarashi; Hiroki Takuma; Takashi Fukuda; Kiichiro Tsutani
Journal:  Pharmacoeconomics       Date:  2009       Impact factor: 4.981

7.  Cost-effectiveness of smoking cessation treatment initiated during psychiatric hospitalization: analysis from a randomized, controlled trial.

Authors:  Paul G Barnett; Wynnie Wong; Abra Jeffers; Sharon M Hall; Judith J Prochaska
Journal:  J Clin Psychiatry       Date:  2015-10       Impact factor: 4.384

Review 8.  The Economic Impact of Smoking and of Reducing Smoking Prevalence: Review of Evidence.

Authors:  Victor U Ekpu; Abraham K Brown
Journal:  Tob Use Insights       Date:  2015-07-14

9.  Development of StopAdvisor: A theory-based interactive internet-based smoking cessation intervention.

Authors:  Susan Michie; Jamie Brown; Adam W A Geraghty; Sascha Miller; Lucy Yardley; Benjamin Gardner; Lion Shahab; Andy McEwen; John A Stapleton; Robert West
Journal:  Transl Behav Med       Date:  2012-09       Impact factor: 3.046

Review 10.  Cost-effectiveness of smoking cessation and the implications for COPD.

Authors:  Michele A Faulkner; Tom L Lenz; Julie A Stading
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2006
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.